Otwarty dostęp

RANKL is a new epigenetic biomarker for the vasomotor symptom during Menopause


Zacytuj

Figure 1

Methylated RANKL patient. The RANKL unmethylated control is purple, methylated control is red. Patient #50 was methylated and patient #52 was unmethylated.
Methylated RANKL patient. The RANKL unmethylated control is purple, methylated control is red. Patient #50 was methylated and patient #52 was unmethylated.

Methylation status of RANKL and FSHR genes in pre- and postmenopausal women.

GenesPostmenopausePremenopausePositive Hot Flashes HistoryNegative Hot Flashes History
RANKL (M) n16 (45.7%)10 (33.3%)12 (75.0%)4 (25.0%)
RANKL (U) n19 (54.3%)20 (66.7%)7 (36.8%)12 (63.2%)
FSHR(M) n18 (51.4%)20 (66.7%)13 (72.2%)5 (27.8%)
FSHR (U) n17 (48.6%)10 (33.3%)6 (35.3%)11 (64.7%)

Methylation status of RANKL and FSHR genes and postmenopausal women who have hot flashes.

GenesPositive Hot Flashes HistoryNegative Hot Flashes Historyp Value
RANKL (M) n12 (75.0%)4 (25.0%)0.024
RANKL (U) n7 (36.8%)12 (63.2%)
FSHR(M) n13 (72.2%)5 (27.8%)0.028
FSHR (U) n6 (35.3%)11 (64.7%)
eISSN:
1311-0160
Język:
Angielski
Częstotliwość wydawania:
2 razy w roku
Dziedziny czasopisma:
Medicine, Basic Medical Science, other